Schizophrenia Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are experiencing their first episode of psychosis and have been diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, or a similar psychosis condition according to standard diagnostic guidelines
• People who are currently experiencing moderate to severe symptoms such as hallucinations, unusual beliefs, feelings of grandiosity, or disorganised thinking, as measured by a standard rating scale
• People who have taken antipsychotic medication for no more than two weeks in total across their lifetime, placing them in the early stage of their illness
• People aged between 15 and 40 years old
• People who are already receiving, or are about to start, treatment with either aripiprazole or risperidone as part of their usual care
• People who have full ability to understand and agree to participate in the study

Who may not be able to join:

• People who choose to withdraw their consent to participate at any point during the study
• People who lose the ability to consent during the course of the study
• People whose treating psychiatrist decides they need a different antipsychotic medication other than aripiprazole or risperidone, for any reason including side effects or poor response
• People where the research team, study sponsor, or an independent safety committee decides it is necessary to remove them from the study for safety reasons
• People who are found to be pregnant during the study

Important: Always verify eligibility with the trial site directly before applying.